Invesco Ltd. Buys Shares of 200,000 Kestra Medical Technologies, Ltd. $KMTS

Invesco Ltd. acquired a new position in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 200,000 shares of the company’s stock, valued at approximately $4,984,000. Invesco Ltd. owned about 0.39% of Kestra Medical Technologies at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Brown Advisory Inc. bought a new stake in Kestra Medical Technologies in the first quarter worth $13,716,000. Federated Hermes Inc. acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $9,968,000. TD Asset Management Inc acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $2,306,000. Jennison Associates LLC acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $1,869,000. Finally, Caas Capital Management LP acquired a new stake in Kestra Medical Technologies in the first quarter worth $1,470,000.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company dropped their price objective on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an “overweight” rating on the stock in a report on Thursday, July 17th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $27.33.

Kestra Medical Technologies Trading Down 2.9%

Shares of Kestra Medical Technologies stock opened at $18.00 on Thursday. Kestra Medical Technologies, Ltd. has a twelve month low of $13.25 and a twelve month high of $26.15. The company has a quick ratio of 6.72, a current ratio of 6.72 and a debt-to-equity ratio of 0.20. The business has a 50-day simple moving average of $16.17.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.